Ascendis Pharma A/S at Canaccord Genuity Growth Conference (Virtual) Transcript
Hi. Good afternoon and thank you for joining us today. My name is Michelle Gilson. I'm one of the biotech analysts here at Canaccord Genuity. I'm so happy to introduce Jan Mikkelsen, the CEO of Ascendis; and Scott Smith, the CFO of Ascendis, a company that we're very excited about as they've really taken the platform to the next level over the course of the last year or so.
So to take us off here, Jan, perhaps. You can just tell us a bit about what you guys are up to at Ascendis. Some of the exciting milestones you have coming up here in the next year or so.
¸ - /- -
Thanks a lot, Michelle. It's a real pleasure here and attending the conference. We at Ascendis, we're a company that is built on a transformative tube technology platform called the TransCon technology.
And by applying this TransCon technology
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
